REVIEW article
Front. Oncol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1593510
This article is part of the Research TopicImmune-Cancer Cell InteractionView all 13 articles
Advances in the Mechanism and Therapeutic Potential of Neutrophil Extracellular Traps in Cancer Promotion
Provisionally accepted- 1The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China
- 2First Clinical Medical College, Henan University of Traditional Chinese Medicine, Zhengzhou, Henan Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Neutrophil extracellular traps (NETs) are chromatin-based structures containing histones and granular proteases released during NETosis. They constitute a key antimicrobial defense mechanism while exposing pathogenic histones. While NET components effectively eliminate microorganisms, their pro-inflammatory and cytotoxic properties inflict significant damage on host endothelial cells and tissues. This damage contributes to diverse pathologies, including autoimmune diseases where NET-derived components act as autoantigens, as well as circulatory disorders, diabetes, and especially, cancer. Recent research has increasingly illuminated the critical connection between NETs and cancer progression, highlighting their role in promoting tumor development across all stages through inflammation and tissue injury. Consequently, targeting NET composition, formation, or release has emerged as a promising therapeutic strategy. These approaches effectively mitigate NET-mediated pathogenesis while circumventing the drawbacks of direct neutrophil depletion. Although translating these strategies into widespread clinical practice presents challenges, experimental studies demonstrate significant potential. This review examines the mechanisms by which NETs drive cancer, explores current therapeutic applications targeting NETs, and discusses both the prospects and challenges of this evolving anticancer approach.
Keywords: Neutrophils, extracellular traps, 促进癌症, Tumer immunity, targeted therapy
Received: 14 Mar 2025; Accepted: 01 Sep 2025.
Copyright: © 2025 Li, Wang, Li, Li, Zhao, Wang and Ren. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Weihong Ren, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.